Drugs

Order of the Supreme Court regarding ART drugs for people living with HIV/AIDS, 24/02/2025

Order of the Supreme Court of India in the matter of Network of People Living With HIV/AIDS & Others Vs Union of India & Others dated 24/02/2025. The Supreme Court (SC), February 24, 2025 has directed all states to file their affidavits addressing concerns raised about antiretroviral therapy (ART) drugs …

Show-cause to Hindustan Antibiotics soon

The Pune division of the Food and Drug Administration (FDA) has decided to serve a show cause notice to the public sector utility Hindustan Antibiotics Limited for violating norms with regards to drugs close to their expiry date. FDA’s joint commissioner ST Patil told DNA on Tuesday that the company …

F.D.A. Issues Alerts on the Heart Drug Multaq

American and European regulators issued safety alerts on Thursday about Multaq, a drug approved two years ago to treat abnormal heart rhythms. The Food and Drug Administration said a study of the drug in patients with a long-term form of the disease, known as atrial fibrillation, showed twice as many …

Chemists plan stir to protest OTC ban

New Delhi: A section of drug dealers in the city has called for a shutdown of chemist shops on August 1 to protest against the government

AstraZeneca Anticlotting Drug Wins Approval

The Food and Drug Administration on Wednesday approved Brilinta, a new blood thinner from AstraZeneca that the company hopes can rival Plavix, the No. 2 best-selling drug in the world. The agency will require a boxed warning about how the drug

Diabetes Drug Dapagliflozin Rejected by F.D.A. Panel

A federal advisory committee voted 9 to 6 on Tuesday that a first-of-its-kind diabetes drug should not be approved for use because of safety concerns, including a possible increased risk of breast and bladder cancers. The advisory committee to the Food and Drug Administration said that while the drug, dapagliflozin, …

`A drug for heart disease, diabetes'

Results from early trials of the drug -designed to improve levels of `good' cholesterol -revealed it stabilises blood sugar levels and reduces risk of heart disease Scientists claim to be developed a drug which can fight both heart disease and Type 2 diabetes. Results from early trials of the drug

Survey finds an alarming decline in population of vultures

Bombay Natural History Society has conducted the survey in wildlife sanctuaries in and around the Nilgiri Biosphere Reserve A field survey on the vulture population in the wildlife sanctuaries in the Nilgiri Biosphere Reserve and adjacent sanctuaries, conducted by the Bombay Natural History Society (BNHS), has found that the number …

HIV percentage slides down to 0.78 per cent in Nagaland

DIMAPUR: HIV prevalence rate in Nagaland has come down to 0.78 per cent since December 2010 from a prevalence rate of 1.27 per cent on October 2010 - a drop of 0.49 per cent. A major concern, however, is that sexual route of transmission has gone up to 89 per …

M.P. silent on 'illegal' drug trials report

Copy of EOW report on irregularities has been leaked to the media Despite its details being published in the local Press, the Madhya Pradesh Government is refusing to comment on the investigation report submitted by the Economic Offences Wing on alleged illegal drug trials conducted by Government doctors in Indore. …

Superbug in the making

THE spectre of superbug still hangs heavily on the residents of Delhi. To make matters worse, another study conducted in the capital has found that cholera bacteria might also be becoming resistant to drugs. Similar results were found in a study conducted at Solapur district of Maharashtra. The studies found …

Children registered for drug trial years before birth

Govt admits irregularities, but not taking action against doctor BHOPAL The registration of children, who were born in the year 2010, was done in 2007 for the quarter venlan study, sponsored by Korea. The issue was raised in the state assembly on Tuesday by MLA Paras Sakhlecha during question hour. …

Two Studies Show Pills Can Prevent H.I.V. Infection

Two new studies released on Wednesday add to the growing body of evidence that taking a daily pill containing one or two AIDS drugs can keep an uninfected person from catching the fatal human immunodeficiency virus. The studies were the first to show protection in heterosexuals; the only earlier one …

Medicines patent pool receives first licence for HIV drugs from major pharmaceutical company

p { margin-bottom: 0.08in; } Gilead Sciences has become the first pharmaceutical company to set up a licensing agreement with the recently-established Medicines Patent Pool (MPP), in a move aimed toward increasing access in developing countries to drugs that treat HIV and Hepatitis B. The landmark deal was announced yesterday, …

Rx Negative, Genetically

Whenever a patient with bleeding in the stomach or a child whose fever has not subsided in a week is admitted into Sasaram-based physician B.B. Singh’s clinic, he immediately knows that it’s a case of self-medication. “At least 40-50 per cent of my patients have either had sleeping pills, or …

The vitamin D-lemma

A vociferous debate about vitamin-D supplementation reveals the difficulty of distilling strong advice from weak evidence.

Bill on biomedical research to be placed before House soon

HYDERABAD, 4 JULY: A comprehensive Bill that aims to regulate and monitor the entire research on the human subjects in the country, will be introduced in Parliament by the end of this year, director general of Indian Council of Medical Research (ICMR), Mr VM Katoch, said today.

FDA Checks Indian Drug Plants

No major deficiency found during inspection of Ranbaxy, Orchid, Emcure, Nectar & Ind Swift Facilities The US drug regulator has inspected manufacturing plants of at least half a dozen Indian drugmakers in the last few weeks, raising hopes among some of these companies that they will shortly be able to …

Transmission Dynamics of Methicillin-Resistant Staphylococcus aureus in a Medical Intensive Care Unit in India

Methicillin-resistant Staphylococcus aureus (MRSA) is a global pathogen and an important but seldom investigated cause of morbidity and mortality in lower and middle-income countries where it can place a major burden on limited resources. Quantifying nosocomial transmission in resource-poor settings is difficult because molecular typing methods are prohibitively expensive. Mechanistic …

289 Essential Bulk Drugs to Come Under Price Control

Medicines made from the bulk drugs constitute a third of the drug market The government plans to bring medicines made from 289 essential bulk drugs, constituting nearly a third of the country

  1. 1
  2. ...
  3. 65
  4. 66
  5. 67
  6. 68
  7. 69
  8. ...
  9. 151

IEP content by date loading...
IEP child categories loading...